Day 1 - Wednesday, 16 October
|Start||End||Session Type||Session Titles|
Presidents Welcome | Opening Lecture
What does the future hold for a child who develops diabetes today?
|10:45||12:15||Plenary session I||
Prevention of type 1 diabetes ,– is it possible?
Lifestyle and insulin resistance: prevention strategies for type 1 diabetes
Nutrional agents in the prevention of type 1 diabetes
The environmental determinants of diabetes in the young (TEDDY) and prospects of prevention
Novo Nordisk Satellite Symposium
Medtronic Satellite Symposium
Evidence for reduced hypoglycaemia exposure: ASPIRE In-Home Study Results
Team-work in diabetes
What do we know about the value of team-work in diabetes?
How can team collaborate to achieve an improved outcome?
How to start up diabetes teams when there are none? The Kenyan experience
Insulin in the neonate and infant - not enough or too much?
Neonatal diabetes; genetics and diagnosis
Congenital Hyperinsulinism: genes, phenotype, treatment and reversion to diabetes
Neonatal diabetes: insulin and sulfonylureas for a holistic approach of the treatment
What is the cause of cerebral edema in diabetic ketoacidosis?
Is cerebral edema caused by cellular or vasogenic edema?
How can cerebral edema during treatment of DKA be avoided?
Do the guidelines need to be changed?
|16:45||18:15||Oral Session I||Acute and chronic complications I|
|16:45||18:15||Oral Session II||Acute and chronic complications II|
|16:45||18:15||Oral Session III||Obesity, puberty and type 2 diabetes|